Completed
Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
NCT03707093
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Horizon Oncology Research Lafayette, Indiana, United States
- NEXT Oncology San Antonio, Texas, United States